Cargando…
Assessing Treatment Effects with Pharmacometric Models: A New Method that Addresses Problems with Standard Assessments
Longitudinal pharmacometric models offer many advantages in the analysis of clinical trial data, but potentially inflated type I error and biased drug effect estimates, as a consequence of model misspecifications and multiple testing, are main drawbacks. In this work, we used real data to compare th...
Autores principales: | Chasseloup, Estelle, Tessier, Adrien, Karlsson, Mats O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093168/ https://www.ncbi.nlm.nih.gov/pubmed/33942179 http://dx.doi.org/10.1208/s12248-021-00596-8 |
Ejemplares similares
-
Generation and application of avatars in pharmacometric modelling
por: Chasseloup, Estelle, et al.
Publicado: (2023) -
Comparison of Seven Non-Linear Mixed Effect Model-Based Approaches to Test for Treatment Effect
por: Chasseloup, Estelle, et al.
Publicado: (2023) -
Pharmacometrics-Based Considerations for the Design of a Pharmacogenomic Clinical Trial Assessing Irinotecan Safety
por: Minichmayr, Iris K., et al.
Publicado: (2021) -
Comparison of covariate selection methods with correlated covariates: prior information versus data information, or a mixture of both?
por: Chasseloup, Estelle, et al.
Publicado: (2020) -
Improved Utilization of ADAS-Cog Assessment Data Through Item Response Theory Based Pharmacometric Modeling
por: Ueckert, Sebastian, et al.
Publicado: (2014)